CYTOKINES IN TUMOR-THERAPY

被引:23
作者
HILL, ADK
REDMOND, HP
CROKE, DT
GRACE, PA
BOUCHIERHAYES, D
机构
[1] BEAUMONT HOSP, DEPT SURG, DUBLIN 9, IRELAND
[2] BEAUMONT HOSP, DEPT BIOCHEM, DUBLIN 9, IRELAND
[3] ROYAL COLL SURG IRELAND, DUBLIN 2, IRELAND
关键词
D O I
10.1002/bjs.1800791005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cytokines are low molecular weight proteins released by cells of the immune system that have therapeutic potential in cancer. They include the interleukins, the interferons, tumour necrosis factor and the colony-stimulating factors. Cytokines are capable of producing significant and sustained responses against a number of tumours. Clinically, the highest response rates to cytokine immunotherapy have been seen in melanoma and renal cell cancer. Current efforts aim to reduce treatment-related toxicity while maintaining the efficacy of cytokines. The therapeutic potential of these agents may be increased with genetic manipulation by introducing genes encoding cytokines into tumour-infiltrating lymphocytes and certain tumour cells. However, immunotherapy remains time consuming and expensive, and further developments are necessary before it can have a definitive role in tumour management.
引用
收藏
页码:990 / 997
页数:8
相关论文
共 145 条
[1]   HIGH-DOSE RECOMBINANT INTERLEUKIN-2 ALONE - A REGIMEN WITH LIMITED ACTIVITY IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA [J].
ABRAMS, JS ;
RAYNER, AA ;
WIERNIK, PH ;
PARKINSON, DR ;
EISENBERGER, M ;
ARONSON, FR ;
GUCALP, R ;
ATKINS, MB ;
HAWKINS, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (14) :1202-1206
[2]  
ABRAMSON SL, 1990, J IMMUNOL, V144, P625
[3]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].
ANTMAN, KS ;
GRIFFIN, JD ;
ELIAS, A ;
SOCINSKI, MA ;
RYAN, L ;
CANNISTRA, SA ;
OETTE, D ;
WHITLEY, M ;
FREI, E ;
SCHNIPPER, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598
[4]  
Aso Y, 1989, Prog Clin Biol Res, V303, P681
[5]   TREATMENT OF METASTATIC RENAL-CELL CANCER-PATIENTS WITH RECOMBINANT SUBCUTANEOUS HUMAN INTERLEUKIN-2 AND INTERFERON-ALPHA [J].
ATZPODIEN, J ;
KORFER, A ;
PALMER, PA ;
FRANKS, CR ;
POLIWODA, H ;
KIRCHNER, H .
ANNALS OF ONCOLOGY, 1990, 1 (05) :377-378
[6]  
BALKWILL FR, 1986, CANCER RES, V46, P3990
[7]   THE CYTOKINE NETWORK [J].
BALKWILL, FR ;
BURKE, F .
IMMUNOLOGY TODAY, 1989, 10 (09) :299-303
[8]   TUMOR NECROSIS FACTOR [J].
BALKWILL, FR .
BRITISH MEDICAL BULLETIN, 1989, 45 (02) :389-400
[9]   INTRATUMORAL LAK CELL AND INTERLEUKIN-2 THERAPY OF HUMAN GLIOMAS [J].
BARBA, D ;
SARIS, SC ;
HOLDER, C ;
ROSENBERG, SA ;
OLDFIELD, EH .
JOURNAL OF NEUROSURGERY, 1989, 70 (02) :175-182
[10]  
BELLOFERNANDEZ C, 1991, IMMUNOLOGY, V72, P161